FDA Media Alert Detail

Drug Shortage

FDA Drug Shortage: Ciprofloxacin Hydrochloride and Hydrocortisone Otic Suspension/Drops

  • U.S. Food and Drug Administration
  • October 30, 2026
  • ID: shortage-ciprofloxacin-hydrochloride-and-hydrocortisone-otic-suspensiondrops-sandoz-inc-66758-087-70

Drug Shortage Details

Generic NameCiprofloxacin Hydrochloride and Hydrocortisone Otic Suspension/Drops
Manufacturer / CompanySandoz Inc.
Therapeutic CategoryAnti-Infective
Availability StatusShortage
Status (FDA list)To Be Discontinued
NDC Package Code66758-087-70
Presentation & Dosage Form

Cipro, Otic Suspension/Drops, 0.2% base, 1% (NDC 66758-087-70)

Manufacturer Contact Info

800-525-8747


Content syndicated from the U.S. Food and Drug Administration (FDA) Drug Shortages Database.